
Figure 1: CHER trial median time of ART received by treatment arm from participants of this study. Light green marks early ART start, orange indicates median time o ART (either before initiation in the deferred arm, or during interruption in the early treatment arms), and dark green represents ART restart aer planned treatment interruption or ART start of continuous ART in the deferred arm. e data reects that of the substudy only, not the CHER trial overall. Median ART interruption time was 13 weeks (IQR = 9.3-248) for Early 40W, and 92 weeks [IQR = 14.3-152] for Early 96W arms. Median deferred time of ART start was 26.1 weeks for Deferred arm [22,23].
Tables at a glance
Figures at a glance